1. Home
  2. STVN vs VNT Comparison

STVN vs VNT Comparison

Compare STVN & VNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • VNT
  • Stock Information
  • Founded
  • STVN 1949
  • VNT 2019
  • Country
  • STVN Italy
  • VNT United States
  • Employees
  • STVN N/A
  • VNT N/A
  • Industry
  • STVN Containers/Packaging
  • VNT Industrial Machinery/Components
  • Sector
  • STVN Consumer Discretionary
  • VNT Industrials
  • Exchange
  • STVN Nasdaq
  • VNT Nasdaq
  • Market Cap
  • STVN 6.3B
  • VNT 5.1B
  • IPO Year
  • STVN 2021
  • VNT N/A
  • Fundamental
  • Price
  • STVN $21.30
  • VNT $32.55
  • Analyst Decision
  • STVN Buy
  • VNT Buy
  • Analyst Count
  • STVN 5
  • VNT 8
  • Target Price
  • STVN $30.60
  • VNT $43.43
  • AVG Volume (30 Days)
  • STVN 386.4K
  • VNT 891.4K
  • Earning Date
  • STVN 10-29-2024
  • VNT 10-31-2024
  • Dividend Yield
  • STVN 0.27%
  • VNT 0.31%
  • EPS Growth
  • STVN N/A
  • VNT 37.59
  • EPS
  • STVN 0.49
  • VNT 2.60
  • Revenue
  • STVN $1,165,359,477.00
  • VNT $3,006,600,000.00
  • Revenue This Year
  • STVN $2.82
  • VNT N/A
  • Revenue Next Year
  • STVN $9.77
  • VNT $4.64
  • P/E Ratio
  • STVN $43.54
  • VNT $12.52
  • Revenue Growth
  • STVN 5.53
  • VNT N/A
  • 52 Week Low
  • STVN $16.56
  • VNT $28.85
  • 52 Week High
  • STVN $35.56
  • VNT $45.62
  • Technical
  • Relative Strength Index (RSI)
  • STVN 57.54
  • VNT 32.36
  • Support Level
  • STVN $20.68
  • VNT $34.36
  • Resistance Level
  • STVN $23.20
  • VNT $35.39
  • Average True Range (ATR)
  • STVN 1.19
  • VNT 0.69
  • MACD
  • STVN 0.20
  • VNT -0.03
  • Stochastic Oscillator
  • STVN 60.74
  • VNT 1.70

About STVN Stevanato Group S.p.A.

Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About VNT Vontier Corporation

Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3.1 billion in sales in 2023.

Share on Social Networks: